BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34260589)

  • 21. VDJServer: A Cloud-Based Analysis Portal and Data Commons for Immune Repertoire Sequences and Rearrangements.
    Christley S; Scarborough W; Salinas E; Rounds WH; Toby IT; Fonner JM; Levin MK; Kim M; Mock SA; Jordan C; Ostmeyer J; Buntzman A; Rubelt F; Davila ML; Monson NL; Scheuermann RH; Cowell LG
    Front Immunol; 2018; 9():976. PubMed ID: 29867956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved SARS-CoV-2 sequencing surveillance allows the identification of new variants and signatures in infected patients.
    Grimaldi A; Panariello F; Annunziata P; Giuliano T; Daniele M; Pierri B; Colantuono C; Salvi M; Bouché V; Manfredi A; Cuomo MC; Di Concilio D; Tiberio C; Fiorenza M; Portella G; Cimmino I; Sorrentino A; Fusco G; Granata MR; Cerino P; Limone A; Atripaldi L; Ballabio A; Cacchiarelli D
    Genome Med; 2022 Aug; 14(1):90. PubMed ID: 35962405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A structured summary of a study protocol for a multi-center, randomized controlled trial (RCT) of COVID-19 prevention with Kampo medicines (Integrative Management in Japan for Epidemic Disease by prophylactic study: IMJEDI P1 study).
    Namiki T; Takayama S; Arita R; Ishii T; Kainuma M; Makino T; Mimura M; Yoshino T; Nogami T; Arai M; Sato J; Tanaka K; Nakae H; Igari H; Ozawa Y; Shiko Y; Kawasaki Y; Nezu M; Ito T
    Trials; 2021 Jan; 22(1):23. PubMed ID: 33407828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic characterization and phylogenetic analysis of SARS-COV-2 in Italy.
    Zehender G; Lai A; Bergna A; Meroni L; Riva A; Balotta C; Tarkowski M; Gabrieli A; Bernacchia D; Rusconi S; Rizzardini G; Antinori S; Galli M
    J Med Virol; 2020 Sep; 92(9):1637-1640. PubMed ID: 32222993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronavirus - A Crippling Affliction to Humans.
    Kaul R; Devi S
    Recent Pat Biotechnol; 2022 Aug; 16(3):226-242. PubMed ID: 35379131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Three Mutations in Italian Strains of SARS-CoV-2: Implications for Pathogenesis.
    Benvenuto D; Benedetti F; Demir AB; Ciccozzi M; Zella D
    Chemotherapy; 2021; 66(1-2):33-37. PubMed ID: 33735872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
    Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
    J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. hCoronavirusesDB: an integrated bioinformatics resource for human coronaviruses.
    Almansour I; Boudellioua I
    Database (Oxford); 2022 Mar; 2022():. PubMed ID: 35348639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner.
    Agrawal H; Das N; Nathani S; Saha S; Saini S; Kakar SS; Roy P
    Stem Cell Rev Rep; 2021 Feb; 17(1):94-112. PubMed ID: 33029768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues.
    D'Antonio M; Nguyen JP; Arthur TD; Matsui H; ; D'Antonio-Chronowska A; Frazer KA
    Cell Rep; 2021 Nov; 37(7):110020. PubMed ID: 34762851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.
    Nambou K; Anakpa M
    Infect Genet Evol; 2020 Nov; 85():104471. PubMed ID: 32707288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019.
    Timberlake DT; Strothman K; Grayson MH
    Curr Opin Allergy Clin Immunol; 2021 Apr; 21(2):182-187. PubMed ID: 33399389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genomic surveillance of Nevada patients revealed prevalence of unique SARS-CoV-2 variants bearing mutations in the RdRp gene.
    Hartley PD; Tillett RL; AuCoin DP; Sevinsky JR; Xu Y; Gorzalski A; Pandori M; Buttery E; Hansen H; Picker MA; Rossetto CC; Verma SC
    J Genet Genomics; 2021 Jan; 48(1):40-51. PubMed ID: 33820739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients.
    Verma S; Abbas M; Verma S; Khan FH; Raza ST; Siddiqi Z; Ahmad I; Mahdi F
    Infect Genet Evol; 2021 Jul; 91():104801. PubMed ID: 33676010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CovidPhy: A tool for phylogeographic analysis of SARS-CoV-2 variation.
    Bello X; Pardo-Seco J; Gómez-Carballa A; Weissensteiner H; Martinón-Torres F; Salas A
    Environ Res; 2022 Mar; 204(Pt A):111909. PubMed ID: 34419470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19: Discovery, diagnostics and drug development.
    Asselah T; Durantel D; Pasmant E; Lau G; Schinazi RF
    J Hepatol; 2021 Jan; 74(1):168-184. PubMed ID: 33038433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An integrative bioinformatics analysis for identifying hub genes associated with infection of lung samples in patients infected with SARS-CoV-2.
    Xie TA; He ZJ; Liang C; Dong HN; Zhou J; Fan SJ; Guo XG
    Eur J Med Res; 2021 Dec; 26(1):146. PubMed ID: 34920753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.